Simon Keady is an experienced healthcare professional currently serving as the Strategic Access Head for Rx Innovative Products in the UK and Ireland at Galderma since August 2023. With a robust background in market access, Simon has held several leadership roles at Biogen, including EU Market Access Lead for Biosimilars and Associate Market Access Director for the UK, Ireland, and the Netherlands. Simon's previous experience includes serving as Director at KOL Research and Development Ltd, Principal Pharmacist at University College London Hospitals, and various senior pharmacist positions across multiple NHS trusts. Simon has advanced education credentials, including an MBA from Lancaster University and a BSc in Pharmacy from the University of Brighton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices